Danny Chichester
Directeur Général chez Services Médicaux Kompas, Inc.
Profil
Danny L.
Chichester is the founder.
He founded Services Médicaux Kompas, Inc. in 2007 and currently holds the titles of Chairman, CEO, Secretary, and Chief Medical Officer.
Dr. Chichester also held former positions at Thallion Pharmaceuticals, Inc. as an Independent Director and at Neomed Institute as VP-Clinical Development & Medical Affairs.
Postes actifs de Danny Chichester
| Sociétés | Poste | Début |
|---|---|---|
Services Médicaux Kompas, Inc.
 Services Médicaux Kompas, Inc. Medical/Nursing ServicesHealth Services Kompas Medical Services, Inc. provides pharmaceutical development services. It offers pre clinical, clinical development, development of medical strategy, evaluation, scientific and medical strategy, optimization of research organization services. It serves to the biotech companies, venture capital firms and other institution in health sciences. The company was founded by Danny L. Chichester in 2007 and is headquartered in Montréal, Canada. | Directeur Général | 01/01/2007 |
Anciens postes connus de Danny Chichester
| Sociétés | Poste | Fin |
|---|---|---|
Neomed Institute
 Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Directeur Technique/Scientifique/R&D | - |
| THALLION PHARMACEUTICALS INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada. | Health Technology |
Services Médicaux Kompas, Inc.
Services Médicaux Kompas, Inc. Medical/Nursing ServicesHealth Services Kompas Medical Services, Inc. provides pharmaceutical development services. It offers pre clinical, clinical development, development of medical strategy, evaluation, scientific and medical strategy, optimization of research organization services. It serves to the biotech companies, venture capital firms and other institution in health sciences. The company was founded by Danny L. Chichester in 2007 and is headquartered in Montréal, Canada. | Health Services |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Health Technology |
